SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001382963-20-000012
Filing Date
2020-01-17
Accepted
2020-01-17 18:13:17
Documents
1
Period of Report
2020-01-15

Document Format Files

Seq Description Document Type Size
1 PRIMARY DOCUMENT edgar.html 4  
1 PRIMARY DOCUMENT edgar.xml 4 3894
  Complete submission text file 0001382963-20-000012.txt   5298
Mailing Address 1880 CENTURY PARK EAST, SUITE 1000 LOS ANGELES CA 90067
Business Address 1880 CENTURY PARK EAST, SUITE 1000 LOS ANGELES CA 90067 310-203-1000
RITTER PHARMACEUTICALS INC (Issuer) CIK: 0001460702 (see all company filings)

IRS No.: 263474527 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations
Office of Life Sciences

Mailing Address C/O RITTER PHARMACEUTICALS INC. 1880 CENTURY PARK EAST, SUITE 1000 LOS ANGELES CA 90067
Business Address
Merino William M. (Reporting) CIK: 0001696626 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-37428 | Film No.: 20534618